2024 Pharma Report
Corporate Reputation26 Sep, 2024
As public expectations rise for the Pharmaceutical industry post-pandemic, companies are confronted with a variety of new reputational challenges. Data from RepTrak’s 2024 Pharma Report reveals that while the industry's global Reputation Score has improved, increased regulations, demands for quick innovations, and shaky relationships with stakeholders are in need of attention.
Read the latest report on our new Reputation Intelligence for Pharma page, and see how Pharma companies can meet the evolving needs of stakeholders.
